BackgroundThe efficacy of surgery alone for patients with locally advanced esophageal cancer (EC) is still unsatisfactory. Presently, induction therapy followed by surgery is the standard treatment. Preoperative chemotherapy (CT) and chemoradiation (CRT) are proven effective induction therapies; however, few sample studies have addressed these treatments, thus, their superiority remains uncertain. We performed a systemic review and meta analysis to test the hypothesis that induction CRT prior to surgery could improve survival compared with induction CT alone. MethodsA comprehensive search of PubMed and the Ovid database for relevant studies comparing EC patients undergoing resection after treatment with induction CT alone or induction CRT...
Purpose: To determine whether CR-S improves survival for resectable cancer of the esophagus. Method:...
Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively ...
Background Most randomized controlled trials (RCTs) that have compared neoadjuvant chemoradiation fo...
Hai-Feng Ma, Guo-Xiao Lv, Zhong-Fang Cai, Da-Hai Zhang Department of Radiotherapy, Dongyang People&...
Background Resectable oesophageal cancer is often treated with surgery alone or with preoperative (n...
OBJECTIVE: This network meta-analysis compared overall survival after neoadjuvant or adjuvant chemot...
ObjectiveThe optimal treatment for resectable esophageal squamous cell carcinoma (ESCC) remains cont...
The efficacy and safety of preoperative chemoradiation therapy (CRT) for advanced esophago-gastric a...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Abstract Background Carcinoma of the esophagus is an aggressive malignancy with an increasing incide...
BACKGROUND. Surgery is the standard treatment for patients with resectable esophageal carcinoma, but...
Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively ...
Background: esophageal cancer is increasingly common and carries a poor prognosis. The optimal tre...
Purpose: To determine whether CR-S improves survival for resectable cancer of the esophagus. Method:...
Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively ...
Background Most randomized controlled trials (RCTs) that have compared neoadjuvant chemoradiation fo...
Hai-Feng Ma, Guo-Xiao Lv, Zhong-Fang Cai, Da-Hai Zhang Department of Radiotherapy, Dongyang People&...
Background Resectable oesophageal cancer is often treated with surgery alone or with preoperative (n...
OBJECTIVE: This network meta-analysis compared overall survival after neoadjuvant or adjuvant chemot...
ObjectiveThe optimal treatment for resectable esophageal squamous cell carcinoma (ESCC) remains cont...
The efficacy and safety of preoperative chemoradiation therapy (CRT) for advanced esophago-gastric a...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Background: Carcinoma of the esophagus is an aggressive malignancy with an increasing incidence. Its...
Abstract Background Carcinoma of the esophagus is an aggressive malignancy with an increasing incide...
BACKGROUND. Surgery is the standard treatment for patients with resectable esophageal carcinoma, but...
Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively ...
Background: esophageal cancer is increasingly common and carries a poor prognosis. The optimal tre...
Purpose: To determine whether CR-S improves survival for resectable cancer of the esophagus. Method:...
Background: The benefit of neoadjuvant chemoradiotherapy in oesophageal cancer has been extensively ...
Background Most randomized controlled trials (RCTs) that have compared neoadjuvant chemoradiation fo...